The Christian-Albrechts-Universität zu Kiel (CAU)

The Christian-Albrechts-Universität zu Kiel (CAU)

uitklapper, klik om te openen

Partner Information uitklapper, klik om te openen

The Christian-Albrechts-Universität zu Kiel (Kiel University, CAU), founded 1665, uses research, teaching and the transfer of science to address the great challenges of our time in health, environmental and cultural change, nutrition and energy. The Faculty of Medicine is committed to medical and dental research and education. It particularly focuses on digital medicine and handling medical datasets. The pre-clinical and clinical-theoretical institutes are located on the CAU campuses, whereas the clinical departments can be found at the University Medical Center Schleswig-Holstein (UKSH) on its main campus in Kiel. The UKSH also consists a second major university hospital which is associated with the University of Lübeck. Both university hospitals are run as one entity making the UKSH one of the largest university medical centres in Europe with over 13.500 employees. 

Departments involved with the STOPSTORM consortium are the departments of Radiation Oncology, of Internal Medicine III (cardiology) and of Radiology and Nuclear Medicine on the UKSH campus in Kiel. The Department of Radiation Oncology in Kiel employs experienced radiation oncologists and is equipped with the latest state-of-the-art radiation therapy systems for conventional radiotherapy, brachy-therapy and stereotactic radiotherapy. It also harbours an inpatient unit for combined radiation-oncologic treatments. The Department of Internal Medicine III (cardiology, angiology and intensive care) in Kiel has a dedicated electrophysiology unit equipped with the latest state-of-the-art catheter laboratory with high resolution epi- and endocardial mapping and ablation systems. The department has a cardiology intensity care unit fully equipped to handle patients with VT.  

Personnel uitklapper, klik om te openen

Dr. Oliver Blanck

Dr. rer. hum. biol. Oliver Blanck is the research coordinator for stereotactic radiotherapy at the Department of Radiation Oncology (Kiel) and the head of operations, medical physics, and R&D at the Saphir Radiosurgery centres in Frankfurt and Kiel. He has 14 years of pioneering experience in STAR and will be responsible for coordinating all the partner activities within STOPSTORM. Dr. Blanck serves on the credentialing and audit committee of STOPSTOPM and as national coordinator will file all needed regulatory work for STOPSTORM for Germany. Dr. Blanck also oversees all activities in the work package quality assessment and assurance (WP4) and is responsible for all deliverables in WP4 for the STOPSTORM project.
In January 2024, Dr. Blanck became coordinator of the STOPSTORM consortium. His responsibilities include the day-to-day management of the STOPSTORM consortium together with the Management Board and Consortium Council.

Publications uitklapper, klik om te openen


EU flag

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945119. Follow us on Twitter and Linkedin.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

This website uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not